Home/Filings/4/0001585364-23-000011
4//SEC Filing

Quinn Grainne 4

Accession 0001585364-23-000011

CIK 0001585364other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 3:24 PM ET

Size

19.3 KB

Accession

0001585364-23-000011

Insider Transaction Report

Form 4
Period: 2023-03-03
Quinn Grainne
EVP, Chief Medical Officer
Transactions
  • Award

    Ordinary Shares

    2023-03-03$38.75/sh+5,419$209,98614,537 total
  • Tax Payment

    Ordinary Shares

    2023-03-03$38.75/sh2,818$109,19811,719 total
  • Exercise/Conversion

    Ordinary Shares

    2023-03-03$38.75/sh+1,052$40,76512,771 total
  • Tax Payment

    Ordinary Shares

    2023-03-03$38.75/sh548$21,23512,223 total
  • Exercise/Conversion

    Ordinary Shares

    2023-03-03$38.75/sh+1,584$61,38013,807 total
  • Tax Payment

    Ordinary Shares

    2023-03-03$38.75/sh824$31,93012,983 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-03-031,0520 total
    Ordinary Shares (1,052 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2023-03-031,5841,583 total
    Ordinary Shares (1,584 underlying)
Footnotes (6)
  • [F1]Vesting of performance-based restricted stock units granted on March 5, 2020.
  • [F2]Vesting of service-based restricted stock units granted on March 5, 2020.
  • [F3]Vesting of service-based restricted stock units granted on March 5, 2021.
  • [F4]Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
  • [F5]Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2021.
  • [F6]Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022.

Issuer

PERRIGO Co plc

CIK 0001585364

Entity typeother

Related Parties

1
  • filerCIK 0001679915

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 3:24 PM ET
Size
19.3 KB